Hypoglycaemic agents were replaced by placebos in diabetic patients attending a hospital clinic. Of 62 patients observed, 43 (69X,) relapsed within six months but blood sugar control remained unchanged in 19 (310o) during the period of observation.
In the pilot study 41 children were Mantoux tested with M. scrofulaceum P.P.D. (Table I) ; only seven were positive, and in all of them the reaction was smaller than that caused by M. avium or Battey P.P.D.
All except one of the 25 children initially grade 1 whose Mantoux reactions indicated possible infection with M. tuberculosis were seen at least 12 months after the Heaf test. Nothing abnormal was found on physical examination or in the chest x-ray picture. Similarly 19 of the 21 children initially Heaf grade 2 were seen; all were normal on physical and radiological examination. One of the 20 children initially grade 3 or 4 had hilar lymph-node enlargement with a Ghon focus and was given anti-tuberculous drugs, 3 showed evidence of a calcified primary complex, and the remaining 16 were clinically and radiologically normal both immediately after the Heaf test and on follow-up at least 12 months later.
Discussion
The purpose of the routine Heaf testing of children aged 12-14 years in the United Kingdom is to separate them into two groups, those requiring B.C.G. vaccination and those requiring investigation of possible M. tuberculosis infection. Hitherto, Heaf-negative children have been vaccinated and Heaf-positive children have been examined clinically and radiologically.
This study of Heaf-positive children in Newham shows that the Heaf test as at present interpreted is too sensitive for this purpose-only 25 (12")0) of 213 children who were initially grade 1 positive were likely to have been infected with M. tuberculosis; the other grade 1 positive reactions were not significant. None of these 25 children, 24 of whom were followed up for at least 12 months, had evidence of active tuberculosis, and our previous experience has been that neither the children with Heaf grade 1 reactions nor their families have active tuberculosis.
Our A. M. TOMKINS, M.B., B.S., M.R.C.P., Registrar ARNOLD BLOOM, M.D., F.R.C.P., Consultant Physician this type of treatment has been extended by the use of other compounds in the sulphonylurea group and by the introduction of the biguanides. From the beginning it had been realized that although oral therapy was successful in reducing blood sugar levels in mild diabetes, the long-term effects were less certain. In particular, it could not be predicted whether or not these compounds would be able to delay the appearance of the degenerative disorders that occur in long-standing diabete. In 1959 a group of American clinicians and statisticians met to discuss this problem and by 1961 a co-operative prospective study had been started in six university centres, later expanded to 12, under the title of the University Group Diabetes Program (1970 Program ( , 1971 .
More than 800 recently diagnosed diabetic patients were assigned at random to various treatment groups. After a followup period ranging from five to eight years it emerged that the death rate from cardiovascular disease, both in the tolbutamidetreated group and in the phenformin-treated group, was sig-nificantly higher than in the placebo group. These unpalatable conclusions have not found support from similar studies in the same field (Keen and Jarrett, 1970; Passikivi, 1970) , and the findings have been criticized for many reasons (British Medical J7ournal, 1970; Constam, 1971; Lancet, 1971 (Table I ). Randomization was achieved by alphabetical selection, and no attempt was made to match the patients in the different groups with regard to age, sex, obesity, or duration of therapy. The mean age was 58-7 years (range 37 to 75) and 45-3% were men. All had been maintained on oral therapy because they had failed to respond to diet alone when first diagnosed. The mean duration of tablet treatment was 3 8 years (range 6 months to 11 years). Patients were requested to maintain their usual diet and to attend each fortnight about two hours after lunch. At each visit blood glucose levels (AutoAnalyzer) and body weight were recorded. For the first three visits previous therapy was maintained. Placebo tablets were then substituted; these were identifiable as different from those previously taken but the total number taken daily was the same.
The degree of control before placebo substitution was assessed by the mean of the three blood glucose levels and classified according to the criteria of Muller et al. (1969) (Table II) . Good (130-150 mg/100 ml) . . Fair (150-180 mg/100 ml)
.. Placebo tablets were maintained so long as the blood glucose levels remained within the same grade. Relapse due to deterioration into a lower grade led to the reintroduction of the previous oral therapy.
Results
Patients were observed until relapse occurred or for a minimum of six months. There were two defaulters from group 4 (phenformin).
Relapse Rate.-Fourteen (870o) patients in group 1 had relapsed within two months (Table III) . Relapse in the sulphonylurea groups 2 and 3 was unaffected by the dosage; 11 (69%,) in each group relapsed within six months. Half of the patients on phenformin (group 4) relapsed within six months. Of the 19 patients who had not relapsed at six months, 16 were followed to 10 months and one only (in group 1) relapsed. Relapse in all patients occurred rapidly and was accompanied by considerable rise in blood glucose (Table III) . All patients who relapsed responded when the former therapy was reintroduced. There was no significant relation between the degree of control and tendency to relapse or between length of previous therapy and tendency to relapse. The degree of obesity was assessed according to the Broca index. As expected there were more obese patients in the phenformin group, and it was in this group that the two defaulters occurred. They would not tolerate the increase in weight which occurred despite satisfactory blood glucose control. There was no significant relation between obesity and tendency to relapse.
Discussion
When oral therapy was first introduced anxiety was felt about the possible immediate dangers of this form of treatment. Hence, tablets were introduced only in mild diabetic patients who could not be restored to normoglycaemia on simple dietary restriction. In one trial the patients treated with tolbutamide in this way were maintained on therapy for six weeks and the tablets were then discontinued. Of 78 such patients, 53 remained well controlled for periods of observation from 4 to 18 months on the same diet that manifestly was inadequate in restoring normoglycaemia before tolbutamide was introduced (Crowley et al., 1957; Bloom, 1959) . In the ensuing years it gradually became apparent that the oral hypoglycaemic agents were largely free from immediate toxic effects and hence tablets have been used more and more widely as long-term treatment. In 1960 at one clinic 42% of patients with diabetes were treated with insulin, 40% were controlled on diet alone, and 180o were taking oral hypoglycaemic agents; by 1968 only 26% were on insulin, 26% were on diet, and 480' were on tablets (Bloom, 1969 (Keen et al., 1965) . It has been the practice in this country to introduce tablets only when simple dietary restriction has failed to restore normo-II glycaemia, and the present trial refers to patients initially treated in this way. Yet, even in these patients, when oral therapy was discontinued 31 " , remained as well controlled as when taking their tablets. These findings suggest that even when the need for tablet therapy has been established by a poor initial response to simple dietary restriction, the introduction of tablets should not be regarded as necessarily permanent. The dose can steadily be reduced and then discontinued if normoglycaemia is maintained. When hyperglycaemia recurs it seems reasonable, in the present state of our knowledge, to reintroduce tablet therapy at the previous effective dose level. There is no firm evidence that insulin is more or less effective than oral therapy in preventing the degenerative complications in diabetics who cannot be controlled on simple dietary restriction.
